POTENTIAL CURE FOR DEBILITATING DISEASE
27/05/14
 
 

Potential cure for debilitating disease

Professor Ranjeny Thomas, Arthritis Queensland Chair of Rheumatology at the UQ Diamantina Institute, works on dendritic cells and autoimmune diseases. In addition to her progress in rheumatoid arthritis, her work has advanced understanding of diabetes and ankylosing spondylitis.

> Read More

A STATE-OF-THE-ART FACILITY
27/02/14
 
 

In 2004 a proposal was submitted to the Queensland Government. In 2007 this progressed to project design. Five years on and $354 million in funding from the Australian and Queensland Governments, The Atlantic Philanthropies, UQ and QUT, TRI became operational and four institutes came together to populate one very special facility. 

Designed by Wilson Architects + Donovan Hill and built by WATPAC, TRI is a 32,000 square metre building making it the largest medical research institute in the southern hemisphere. 

It includes four floors of laboratory research plus facilities for research support, administration and teaching. A bio-pharmaceutical manufacturing facility led by Patheon with fermentation capacity is adjacent to the main TRI building. 

Patheon will assist new biological drug developers and provide cutting-edge technical and economical methods for producing clinical grade biopharmaceutical compounds.

> Read More

BENCH TO BEDSIDE
14/01/14
 
 

Bench to bedside

TRI is unique in Australia. Its focus is getting the benefits of medical research out to the community rapidly, efficiently and for the benefit of Australia and Australians. To achieve this, TRI first brings together the best researchers from four leading institutions: University of Queensland Diamantina Institute (UQDI), Queensland University of Technology Institute of Health and Biomedical Innovation (IHBI), Mater Research and the Princess Alexandra Hospital’s Centres for Research. 

> Read More

COLLECTIVE INTELLIGENCE
21/11/13
 
 

Four institutes coming together as one

TRI accelerates the time between a laboratory discovery and its use in the community. Led by Professor Ian Frazer as Chief Executive Officer and Director of Research, TRI integrates the collective expertise of the University of Queensland Diamantina Institute (UQDI), Queensland University of Technology Institute of Health and Biomedical Innovation (IHBI), Mater Research and the Princess Alexandra Hospital’s Centres for Research.

> Read More